PRECISION FOR MEDICINE
Precision for Medicine is the first global, precision-medicine, clinical research organization. Purpose-built to shift the development curve for life sciences clients, we incorporate laboratory expertise, new technologies, clinical trial excellence, comprehensive biospecimens solutions and advanced data sciences at every stage. Our integrated approach is designed to maximize insights into patient biology and to accelerate the pace of scientific discovery and approval. With 7 specialty labs and 3000+ professionals worldwide, we help accelerate life-changing treatments anywhere around the globe.
Certara accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. Its clients include 1,650 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 61 countries. Our unique and regulatory-ready models for immunogenicity, immune-oncology, rare disease, vaccines, and gene therapy are used by major pharmaceutical and emerging biotech companies.
Codexis is a leading protein engineering company leveraging its proprietary CodeEvolver® platform to discover, improve and develop novel biotherapeutics and performance enzymes. CodeEvolver® drives our Biotherapeutics discovery pipeline of oral GI-active enzyme therapies, evolved transgenes, and next generation AAV capsids and promoters. Codexis proteins enable the promise of synthetic biology to improve the health of people and the planet.
KCAS, FlowMetric and Active Biomarkers have united as the KCAS family of companies. We are rapidly growing as a leading contract research organization (CRO), employing top scientific talent in the lab and supportive front office teams to provide exceptional customer service. We are uniquely positioned to provide comprehensive bioanalytical services to the global biopharmaceutical industry from early discovery support through product registration and beyond. The collaboration of the three entities allows for global support in bioanalytical, biomarker and cellular and molecular assay services along with clinical kitting and sample management. The KCAS family of companies operate in state-of-the-art facilities located in Kansas City and Philadelphia, USA, Milan, Italy and Lyon, France with significant expansion opportunities. The combined business structure provides the expertise, capacity and flexibility to support the development of all types of drugs, biologics, cell and gene therapies to improve health worldwide.